ARTICLE | Company News
Neuro3d neurology news
October 16, 2006 7:00 AM UTC
Neuro3d said it is winding down its operations and has terminated development of its ND1251 and ND7001. The compounds, which inhibit phosphodiesterase-4 (PDE-4) and PDE-2, respectively, showed toxici...